CNTB (Connect Biopharma Holdings) Other Long-Term Liabilities : $0.63 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Connect Biopharma Holdings Other Long-Term Liabilities?

Connect Biopharma Holdings's other long-term liabilities for the quarter that ended in Dec. 2024 was $0.63 Mil.

Connect Biopharma Holdings's quarterly other long-term liabilities declined from Dec. 2023 ($0.41 Mil) to Jun. 2024 ($-0.00 Mil) but then increased from Jun. 2024 ($-0.00 Mil) to Dec. 2024 ($0.63 Mil).

Connect Biopharma Holdings's annual other long-term liabilities increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.41 Mil) and increased from Dec. 2023 ($0.41 Mil) to Dec. 2024 ($0.63 Mil).

Connect Biopharma Holdings Other Long-Term Liabilities Historical Data

The historical data trend for Connect Biopharma Holdings's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Connect Biopharma Holdings Other Long-Term Liabilities Chart

Connect Biopharma Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

317.07

0.41

0.63

Connect Biopharma Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Long-Term Liabilities	Get a 7-Day Free Trial						-	-	0.41	-	0.63

Connect Biopharma Holdings Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Connect Biopharma Holdings Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Connect Biopharma Holdings's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Connect Biopharma Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Connect Biopharma Holdings Ltd (NAS:CNTB) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

12265 El Camino Real, Suite 350, San Diego, CA, USA, 92130

Website

https://www.connectbiopharm.com

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.